Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Ezabenlimab and BI 907828 in Adult Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study of TYRA-300 for Patients with Advanced Bladder Cancer and Other Solid Tumors with FGFR3 Gene Changes

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Italy Spain
  • Study of ALX148, Pembrolizumab, and Chemotherapy for Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium The Netherlands Spain
  • Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Czechia Hungary Italy Poland Spain
  • A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Poland +1
  • Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

    Not recruiting

    1 1 1
    Investigated Drugs:
    France Poland
  • Study on the Safety and Effectiveness of AZD7789 for Patients with Advanced or Metastatic Solid Tumors, Including Non-small Cell Lung Cancer and Gastric Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France The Netherlands Spain
  • Study for Patients with cMET-Dependent Cancers to Continue Treatment with Capmatinib, Nazartinib, and Gefitinib

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Germany Italy
  • Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy Spain
  • Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Spain